Securities code: 300110 securities abbreviation: Huaren Pharmaceutical Co.Ltd(300110) Announcement No.: 2021-074 Huaren Pharmaceutical Co.Ltd(300110)
Announcement on the reduction of more than 1% by shareholders holding more than 5%
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Recently, Huaren Pharmaceutical Co.Ltd(300110) (hereinafter referred to as " Huaren Pharmaceutical Co.Ltd(300110) " or "the company") received the notification letter from Huaren Century Group Co., Ltd. (hereinafter referred to as "Huaren Century Group"), from March 4, 2020 (i.e. the announcement date of the last reduction ratio of 1%, see the company's Announcement No. 2020-013) to December 24, 2021, Huaren Century Group's share reduction ratio of the company has reached Huaren Pharmaceutical Co.Ltd(300110) 1.06% of the total share capital. In accordance with the relevant provisions of the Shenzhen Stock Exchange GEM Listing Rules, the progress of share reduction is hereby notified as follows:
1、 Reduction of Huaren Century Group 1 Basic information
Information disclosure obligor: Huaren Century Group Co., Ltd
Address: 27 / F, Huaren international building, No. 2, Shandong Road, Shinan District, Qingdao, Shandong Province
Equity change time: August 3, 2020 to December 24, 2021
Stock abbreviation Huaren Pharmaceutical Co.Ltd(300110) stock code 300110
Change type increase □ decrease whether there are persons acting in concert
(multiple choices are allowed)
Whether it is the largest shareholder or actual controller yes □ no
2. Changes in equity
Type of shares number of shares reduced (10000 shares) reduction proportion (%)
A shares 1252.42401 06
Total 1252.42401 06
Transfer through centralized trading agreement of stock exchange □
Block trading through stock exchange □ indirect transfer □
Method of this equity change (administrative transfer or change of multi-national shares □ execution of court ruling □
(optional) acquisition of new shares issued by listed companies □ succession □
Gift □ transfer of voting rights □
Others □ (please specify)
3. Shares of listed companies owned by investors and persons acting in concert before and after the change
Nature of shares shares held before this change shares held after this change
Number of shares (10000 shares) in total share capital proportion of shares (10000 shares) in total share capital (%) (%)
The total number of shares held is 12856.641610 8811604.21769. eighty-two
Including: shares with unlimited sales conditions 12856.641610 8811604.21769. eighty-two
Shares with limited sales conditions 0000
4. Implementation of commitments, plans, etc
Yes no □
If yes, please explain the commitment, intention, specific situation of the plan and the progress of implementation.
1. Huaren Pharmaceutical Co.Ltd(300110) disclosed the announcement on the expiration of the reduction plan of shareholders holding more than 5% and the pre disclosure of the subsequent reduction plan on June 2, 2020, Announcement No.: 2020-038, Huaren Century Group plans to reduce the number of Huaren Pharmaceutical Co.Ltd(300110) shares through centralized bidding trading at the stock exchange within six months from the date of announcement of the reduction plan (i.e. not more than 2% of the total share capital of Huaren Pharmaceutical Co.Ltd(300110) ).
2. Huaren Pharmaceutical Co.Ltd(300110) disclosed the announcement on the expiration of the reduction plan of shareholders holding more than 5% and the pre disclosure of the subsequent reduction plan on December 24, 2020, Announcement No.: 2020-080. Huaren Century Group plans to within six months after 15 trading days from the date of the announcement of the reduction plan, The number of Huaren Pharmaceutical Co.Ltd(300110) shares to be reduced through centralized bidding trading at the stock exchange shall not exceed 23644200 shares (i.e. not more than 2% of the total share capital of the company).
Whether this change is performed or not 3 Huaren Pharmaceutical Co.Ltd(300110) on July 19, 2021, it disclosed the announcement on the commitment, intention, plan expiration and pre disclosure of subsequent reduction plan made by shareholders holding more than 5%, Announcement No.: 2021-039. Huaren Century Group plans to conduct centralized bidding transactions within 6 months after 15 trading days from the date of announcement of reduction plan The reduction of shares by block trading shall not exceed 6% of the total share capital of Huaren Pharmaceutical Co.Ltd(300110) . Among them, if the shares are reduced by centralized bidding trading, the number of shares reduced shall not exceed 2% of the total shares of the company within 6 months after 15 trading days from the date of announcement of the reduction plan; In case of reduction through block trading, the number of shares reduced shall not exceed 4% of the total shares of the company within 6 months after 3 trading days from the date of announcement of the reduction plan.
4. Huaren Pharmaceutical Co.Ltd(300110) disclosed the announcement on the implementation progress of the reduction plan for shareholders holding more than 5% on November 9, 2021, Announcement No.: 2021-065. As of November 9, 2021, the period of the reduction plan of Huaren Century Group has exceeded half, and 2128000 shares have been reduced in total during the period of the reduction plan.
This reduction is consistent with the previously disclosed reduction plan. The reduction plan disclosed by Huaren Pharmaceutical Co.Ltd(300110) on July 19, 2021 has not been fully implemented.
Is there any violation of the securities law and the purchase of Listed Companies in this change
Purchase management measures and other laws and regulations yes □ no
If yes, please specify the specific situation, rectification plan and treatment measures of the violation.
5. Compliance with relevant documents and the business rules of the exchange Shares with restricted voting rights
In accordance with Article 63 of the securities law yes □ no
If yes, please explain the proportion of the corresponding number of shares in the share capital of the existing listed company. Voting shares
2、 For reference document 1. The notice letter of Huaren Century Group Co., Ltd. on reducing the proportion of Huaren Pharmaceutical Co.Ltd(300110) shares by more than 1% is hereby announced.
Huaren Pharmaceutical Co.Ltd(300110) board of directors December 24, 2001
